NCT04733729View on ClinicalTrials.gov

Covid-19 in Hematological Malignancies

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

September 30, 2022

Study Completion Date

December 31, 2025

Conditions
COVID-19 Infection in Hematological Malignancies Patients
Trial Locations (6)

Unknown

RECRUITING

ASST-Spedali Civili, Brescia

RECRUITING

AOU Policlinico Federico II, Napoli

RECRUITING

Fondazione Policlinico A. Gemelli IRCCS, Rome

RECRUITING

Istituto Nazionale Tumori Regina Elena IFO, Rome

RECRUITING

Osp. di Circolo-Fondazione Macchi, Varese

RECRUITING

AOUI Verona, Verona

All Listed Sponsors
collaborator

European Hematology Association

UNKNOWN

lead

Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne

OTHER